Viridian Therapeutics, Inc.\DE (VRDN) Treasury Shares (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Treasury Shares of $1.6 million for Q1 2026, up 45.2% year-over-year from $1.1 million in Q1 2025, and up 53.95% quarter-over-quarter from $1.1 million in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Treasury Shares (2014 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Treasury Shares history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 45.2% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 45.2% YoY), while the FY2025 annual figure was $1.1 million, up 238.89% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.6 million, up from $1.1 million in the prior quarter.
- The five-year high for Treasury Shares was $1.6 million in Q1 2026, with the low at $250000.0 in Q1 2023.
- The 4-year median for Treasury Shares is $804947.0 (2023), against an average of $838860.6.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares tumbled 60.98% in 2024, then surged 238.89% in 2025.
- Viridian Therapeutics, Inc.\DE's Treasury Shares stood at $804947.0 in 2023, then sank by 60.98% to $314075.0 in 2024, then soared by 238.89% to $1.1 million in 2025, then jumped by 53.95% to $1.6 million in 2026.
- Business Quant data shows VRDN's Treasury Shares at $1.6 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 314,075.00 |
| Dec 31, 2024 | 314,075.00 |
| Jun 30, 2024 | 589,696.00 |
| Jun 30, 2024 | 589,696.00 |
| Mar 31, 2024 | 669,096.00 |
| Mar 31, 2024 | 669,096.00 |
| Dec 31, 2023 | 804,947.00 |
| Dec 31, 2023 | 804,947.00 |
| Mar 31, 2023 | 250,000.00 |
| Mar 31, 2023 | 250,000.00 |